A SPAC III Acquisition Corp.

closed
ASPCSEC EDGARCIK: 0001890361|A SPAC III (Holdings) Corp.Bio-based antimicrobial materials

Capital Structure & Economics

Trust Size$55,000,000
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

No Warrants / No Drag
Public Trust Allocation$55,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedOct 1, 2024
Target AnnouncedMay 23, 2025
Maturation Wall
Nov 12, 2026

Announced Target / M&A

  • Target CompanyBioserica International Limited
  • SectorBio-based antimicrobial materials
  • Announced Deal Size$217,860,000
  • Announcement Date2025-05-23

Board & Officers

Advanced Structuring Terms

Target SectorsBio-based antimicrobial materials

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.